PlainRecalls
FDA Drug Moderate Class II Terminated

Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC 60505-2676-3, UPC 3 60505 26763 7), Rx only, Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326

Reported: July 27, 2022 Initiated: July 7, 2022 #D-1285-2022

Product Description

Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC 60505-2676-3, UPC 3 60505 26763 7), Rx only, Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326

Reason for Recall

Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.

Details

Recalling Firm
Apotex Corp.
Units Affected
2010 bottles
Distribution
USA Nationwide
Location
Weston, FL

Frequently Asked Questions

What product was recalled?
Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC 60505-2676-3, UPC 3 60505 26763 7), Rx only, Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326. Recalled by Apotex Corp.. Units affected: 2010 bottles.
Why was this product recalled?
Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 27, 2022. Severity: Moderate. Recall number: D-1285-2022.